0001209191-17-056693.txt : 20171011
0001209191-17-056693.hdr.sgml : 20171011
20171011192705
ACCESSION NUMBER: 0001209191-17-056693
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171010
FILED AS OF DATE: 20171011
DATE AS OF CHANGE: 20171011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dier Mardi
CENTRAL INDEX KEY: 0001574591
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 171133577
MAIL ADDRESS:
STREET 1: PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-10
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001574591
Dier Mardi
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
1
0
0
0
Stock Option (Right to Buy)
21.69
2017-10-10
4
A
0
30000
0.00
A
2027-10-09
Common Stock
30000
30000
D
1/3rd of the shares subject to the option shall vest and become exercisable on each of 10/10/2018, 10/10/2019 and 10/10/2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
/s/ Jennifer Rhodes, Attorney-in-fact
2017-10-11